We have over 25 programs1 in pre-clinical and clinical development across our partner companies that span several large-market areas, including oncology, rare diseases and gene therapy, which allow us to create value for shareholders.
Includes product candidates in development at Fortress, its majority-owned and majority-controlled partner companies and entities in which it holds minority ownership positions
At the center of Fortress Biotech is a business development engine that focuses on building our product portfolio through flexible deal-structuring, including conventional licensing, partnership arrangements, joint ventures, option agreements and others.View Our Business Development
We recognize our success is a product of the numerous contributions of our executive officers, scientific, financial, legal, technical personnel and consultants. As we continue to implement our growth strategy, as well as acquire and develop technologies, we will continue to rely on their expertise and dedication.